In the article by Yang et al, “Genetic Landscape of the ACE2 Coronavirus Receptor” which published in the May 3, 2022, issue of the journal (Circulation. 2021;145:1398–1411. doi: 10.1161/CIRCULATIONAHA.121.057888), a correction is needed.

The incorrect author was listed in the first line of the Disclosures section. The Disclosures should read as follows:

Dr Butterworth has received grants outside of this work from AstraZeneca, Bayer, Biogen, Bioverativ, Merck, Novartis, Pfizer, and Sanofi. Dr Dermitzakis is currently an employee of GSK, and the work was performed before he joined GSK. The other authors report no conflicts.

This correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057888.

在 Yang 等人发表在 2022 年 5 月 3 日期刊上的文章《ACE2 冠状病毒受体的遗传景观》（Circulation . 2021;145:1398–1411.doi: 10.1161/CIRCULATIONAHA.121.057888）中，需要更正。

错误的作者被列在“披露”部分的第一行中。披露内容应如下：

除这项工作外，巴特沃斯博士还获得了阿斯利康、拜耳、百健、Bioverativ、默克、诺华、辉瑞和赛诺菲的资助。Dermitzakis 博士目前是 GSK 的员工，这项工作是在他加入 GSK 之前进行的。其他作者报告没有冲突。

此更正已针对该文章的当前在线版本进行，可在 https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057888 上获取。